Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anthracycline and anthraquinone anticancer agents: current status and recent developments

J W Lown1

  • 1Department of Chemistry, University of Alberta, Edmonton, Canada.

Pharmacology & Therapeutics
|November 1, 1993
PubMed
Summary

Chemotherapy has evolved significantly, leading to the discovery of natural anticancer agents like anthracyclines. Research focuses on developing less toxic drugs and understanding their mechanisms for improved cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA Sequence Recognition of a Cross-Linked Polyamide: CD Studies, Footprinting and Effects on the Activity of DNA Gyrase.

Journal of biomolecular structure & dynamics·2012
Same author

Novel cyclopropylindole conjugates and dimers: synthesis and anti-cancer evaluation.

Current medicinal chemistry. Anti-cancer agents·2003
Same author

DNA sequence recognition of thiazole-containing cross-linked polyamides can be favored.

Journal of biomolecular structure & dynamics·2002
Same author

Ab initio studies of the reaction of hydrogen transfer from DNA to the calicheamicinone diradical.

Molecular medicine (Cambridge, Mass.)·2002
Same author

A general solution- and solid-phase synthetic procedure for incorporating three contiguous imidazole moieties into DNA sequence reading polyamides.

The Journal of organic chemistry·2001
Same author

Recent developments in sequence selective minor groove DNA effectors.

Current medicinal chemistry·2001

Area of Science:

  • Oncology
  • Medicinal Chemistry
  • Biochemical Pharmacology

Background:

  • Chemotherapy has evolved from early alkylating agents to a rationally based discipline significantly impacting cancer management.
  • The identification of promising natural anticancer agents highlighted the need for less toxic drug candidates.
  • Medicinal chemistry efforts, particularly analog development of anthraquinones, have yielded clinical leads.

Purpose of the Study:

  • To summarize the discovery and mechanisms of action of anthracyclines.
  • To review efforts aimed at improving the therapeutic efficacy of anthracyclines.
  • To provide insight into the evolution of chemotherapy and its future challenges.

Main Methods:

  • Review of historical data on chemotherapy development.

Related Experiment Videos

  • Analysis of biochemical pharmacology studies on anticancer agents.
  • Exploration of synthetic organic and microbial chemistry in drug discovery.

    • Main Results:

    • Anthracyclines, exemplified by doxorubicin, are effective cytotoxic agents.
    • Understanding drug metabolism and mechanisms of action has deepened.
    • New cellular targets like topoisomerases and helicases present synthetic challenges.

    Conclusions:

    • Chemotherapy has made significant strides, with anthracyclines remaining a cornerstone treatment.
    • Ongoing research focuses on developing safer and more effective anticancer drugs.
    • The field faces new challenges with the identification of novel drug targets.